Effects of t-ACPD on neural survival and second messengers in cultured cerebral cortical neurons

NeuroReport

Volumn 4, Issue 11, 1993, Pages 1255-1258

  Thomsen, Christian ^a   Frandsen, Aase ^b   Suzdak, Peter D ^a   Andersen, Charlotte F ^b   Schousboe, Arne ^b  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

(1s 3r) 1 amino cyclopentane 1; 3 dicarboxylic acid (t ACPD); Cyclic AMP; Intracellular ca2+; Metabotropic glutamate receptor; Neurotoxicity; Phosphoinositide hydrolysis

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; CYCLIC AMP; ENDOGENOUS COMPOUND; FORSKOLIN; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMIC ACID; INOSITOL PHOSPHATE; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; MOUSE; NERVE CELL; NONHUMAN; SECOND MESSENGER;

ANIMAL; CALCIUM; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CYCLIC AMP; CYCLOLEUCINE; FORSKOLIN; HYDROLYSIS; LACTATE DEHYDROGENASE; MICE; N-METHYLASPARTATE; NEURONS; PHOSPHATIDYLINOSITOLS; RECEPTORS, METABOTROPIC GLUTAMATE; SECOND MESSENGER SYSTEMS; SUPPORT, NON-U.S. GOV'T;

EID: 0027379881     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/00001756-199309000-00011     Document Type: Article

References (25)

1. Farooqui AA and Horrocks LA. Brain Res Rev 16, 171-191 (1991).
2. Schoepp DD, Bockaert J and Sladeczek F. Trends Pharmacol Sci 11, 508-515 (1990).
3. Schoepp DD and Conn PJ. Trends Pharmacol Sci 14,13-20 (1993).
4. Houamed KM, Kuijper JL and Gilbert TL et al. Science 252, 1318-1321 (1991).
5. Tanabe Y, Masu M, Ishii T et al. Neuron 8, 169-179 (1992).
6. Tanabe V, Nomura A, Masu M et al. J Neurosci 13, 1372-1378 (1993).
7. Abe T, Sugihara H, Nawa H et al. J Biol Chem 267, 13361-13368 (1992).
8. Aramori I and Nakanishi S. Neuron 8, 757-765 (1992).
9. Thomsen C, Kristensen P, Mulvihill E et al. Eur J Pharmacol Mol Pharmacol Secf 227, 361-362 (1992).
10. Palmer E, Monaghan DT and Cotman CW. Eur J Pharmacol 166, 585-587 (1989).
11. Frandsen A, Drejer J and Schousboe A. J Neurochem 53, 297-299 (1989).
12. Frandsen A and Schousboe A. J Neurochem 60, 1202-1211 (1993).
13. Koh J-V, Palmer E, Lin A et al. Brain Res 561, 338-343 (1991).
14. Koh J-V, Palmer E and Cotman CW. Proc Natl Acad Sci USA 88, 9431-9435 (1991).
15. Aleppo G, Pisani A, Copani A et al. Adv Exp Med Biol 318, 137-145 (1992).
16. Frandsen A and Schousboe A. Proc Natl Acad Sci USA 89, 2590-2594 (1992).
17. Berridge MJ, Downes CP and Hailey MR. Biochem J 206, 587-595 (1982).
18. Belhage B, Hansen GH and Schousboe A. Neuroscience. In press (1993).
19. Kawai M, Horikawa Y and Ishihara T. Eur J Pharmacol 211,195-202 (1992).
20. Schousboe A, Drejer J, Hansen GH et al. Dev Neurosci 7, 252-262 (1985).
21. Bessho Y, Nakanishi S and Nawa H. Mol Brain Res 18, 201-208 (1993).
22. Hayashi Y, Tanabe Y, Aramori I et al. BrJ Pharmacol 107, 539-543 (1992).
23. Barry J, Ogura A and Kudo Y. Eur J Neurosci 3, 1146-1154 (1991).
24. Baba A and Hashimoto H. Neurosci Lett 149,182-184 (1993).
25. Miller S, Cotman CW and Bridges RJ. J Neurochem 58, 1967-1970 (1992).